Avadel Pharmaceuticals PLC
NASDAQ:AVDL
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
Price:
15.79 USD
1.28%
Updated:
May 30, 2024
Avadel Pharmaceuticals PLC
Cash from Financing Activities
|
Avadel Pharmaceuticals PLC
Cash from Financing Activities Peer Comparison
Comparables:
PRGO
JAZZ
G
GHRS
COPN
OVB
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
|
Cash from Financing Activities
$114.1m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
3%
|
|
|
Perrigo Company PLC
NYSE:PRGO
|
Cash from Financing Activities
-$196.9m
|
CAGR 3-Years
12%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
|
Cash from Financing Activities
-$305.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
G
|
GH Research PLC
NASDAQ:GHRS
|
Cash from Financing Activities
-$204k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cosmo Pharmaceuticals NV
SIX:COPN
|
Cash from Financing Activities
-€209.3m
|
CAGR 3-Years
-160%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Ovoca Bio PLC
LSE:OVB
|
Cash from Financing Activities
€888k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-9%
|
See Also
What is Avadel Pharmaceuticals PLC's Cash from Financing Activities?
Cash from Financing Activities
114.1m
USD
114.1m
USD
Based on the financial report for Mar 31, 2024, Avadel Pharmaceuticals PLC's Cash from Financing Activities amounts to 114.1m USD.
What is Avadel Pharmaceuticals PLC's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
3%
3%
Over the last year, the Cash from Financing Activities growth was 143%. The average annual Cash from Financing Activities growth rates for Avadel Pharmaceuticals PLC have been -1% over the past three years , and 3% over the past ten years .
You don't have any saved screeners yet
